Randomised controlled trial investigating the effects of early snake antivenom administratio

Not Applicable

• Conditions: Myotoxicity; Snake envenoming; neurotoxicity; major bleeding; renal impairment; Musculoskeletal - Other muscular and skeletal disorders; Injuries and Accidents - Poisoning

• Registration Number: ACTRN12615000264583
• Lead Sponsor: niversity of Newcastle

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-03-20
• Study Completion: 2015-10-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

1.Presents to hospital within 2 hours of snakebite
2.Definite sighting of a snake by the patient (or parent/carer of child, age >2years) and a confirmed bite.
3.Early non-specific systemic symptoms suggesting envenoming: EITHER: collapse OR two of vomiting, headache, diarrhoea or abdominal pain.

Exclusion Criteria

1.Aged under 2 years of age
2.Definite bite by a non-venomous snake
3.Definite bite by a red-bellied black snake at hospitals where a separate study is being undertaken (Hunter Area Health Hospitals, Manning Base Hospital, Coffs Harbour Hospital, Liverpool Hospital, Campbelltown Hospital)
4.Suspected taipan bites (in northern regions of Australia where taipans occur)
5.Cases consistent with mulga snake envenoming
6.Cases consistent with death adder envenoming
7.Cardiac Arrest.

Study & Design

• Study Type: Interventional
• Study Design: Not specified